My HPRA: Register

LAMISIL AT

1.0 %w/w Cream

GlaxoSmithKline Consumer Healthcare (Ireland) LimitedPA0678/121/002

Main Information

Trade NameLAMISIL AT
Active SubstancesTERBINAFINE HYDROCHLORIDE
Strength1.0 %w/w
Dosage FormCream
Licence HolderGlaxoSmithKline Consumer Healthcare (Ireland) Limited
Licence NumberPA0678/121/002

Group Information

ATC CodeD01AE15 Antifungals for systemic use

Status

Authorised/WithdrawnAuthorised
Licence Issued29/07/2016
Supply StatusSupply through pharmacies only
Dispensing StatusProduct not subject to medical prescription
Marketing StatusMarketed
Promotion StatusPromotion to the general public
Conditions of LicenceRetail sales through pharmacies subject to the following restrictions: maximum strength: 1.0%, maximum pack size: 15g, maximum period of treatment: 14 days, products other than spray solutions, limited indications: treatment of tinea cruris (jock or dhobie itch) and tinea pedis (athlete's foot), use in adults and children over 16 years.

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print